Want to see DE:MAK full AI Analyst Report?
MATERNUS-Kliniken AG (MAK) Ratios
MATERNUS-Kliniken AG Ratios
DE:MAK's free cash flow for Q2 2026 was $3.85M. For the 2026 fiscal year, DE:MAK's free cash flow was decreased by $-1.63M and operating cash flow was $5.49M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.21 | 0.13 | 0.30 | 0.30 | 0.48 |
| Quick Ratio | 0.20 | 0.13 | 0.30 | 0.29 | 0.47 |
| Cash Ratio | 0.04 | 0.02 | 0.01 | 0.04 | 0.26 |
| Solvency Ratio | -0.02 | -0.00 | -0.02 | -0.02 | 0.05 |
| Operating Cash Flow Ratio | 0.15 | 0.11 | 0.03 | 0.08 | 0.36 |
| Short-Term Operating Cash Flow Coverage | 0.21 | 0.13 | 7.21 | 12.37 | 0.73 |
| Net Current Asset Value | $ -210.83M | $ -189.70M | $ -182.95M | $ -174.06M | $ -164.07M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 1.22 | 1.18 | 0.73 | 0.77 | 0.75 |
| Debt-to-Equity Ratio | -2.27 | -2.47 | -2.09 | -3.00 | -4.88 |
| Debt-to-Capital Ratio | 1.79 | 1.68 | 1.92 | 1.50 | 1.26 |
| Long-Term Debt-to-Capital Ratio | -2.23 | -0.00 | 261.96 | 3.63 | 1.87 |
| Financial Leverage Ratio | -1.86 | -2.09 | -2.87 | -3.90 | -6.53 |
| Debt Service Coverage Ratio | 0.04 | 0.07 | 0.38 | 0.08 | 0.49 |
| Interest Coverage Ratio | -0.76 | -0.47 | -1.23 | 2.80 | 0.18 |
| Debt to Market Cap | 5.74 | 3.93 | 0.91 | 1.56 | 0.76 |
| Interest Debt Per Share | 9.12 | 8.29 | 5.72 | 5.89 | 6.18 |
| Net Debt to EBITDA | 44.02 | 15.18 | 23.71 | 67.61 | 7.43 |
| Profitability Margins | |||||
| Gross Profit Margin | 19.49% | 86.65% | 85.47% | 81.52% | 87.51% |
| EBIT Margin | -4.02% | -1.62% | -4.92% | -8.72% | 3.45% |
| EBITDA Margin | 3.45% | 9.39% | 4.61% | 1.60% | 13.43% |
| Operating Profit Margin | -5.18% | -3.50% | -9.05% | 15.17% | 1.00% |
| Pretax Profit Margin | -10.81% | -9.01% | -12.30% | -14.13% | -1.94% |
| Net Profit Margin | -11.78% | -11.54% | -13.94% | -13.19% | -2.30% |
| Continuous Operations Profit Margin | -11.74% | -11.54% | -13.94% | -15.31% | -2.41% |
| Net Income Per EBT | 108.96% | 128.05% | 113.30% | 93.35% | 118.24% |
| EBT Per EBIT | 208.62% | 257.65% | 135.87% | -93.16% | -194.96% |
| Return on Assets (ROA) | -9.27% | -9.41% | -9.24% | -9.18% | -1.55% |
| Return on Equity (ROE) | 17.25% | 19.68% | 26.52% | 35.82% | 10.10% |
| Return on Capital Employed (ROCE) | -10.95% | -56.50% | -12.04% | 16.68% | 0.94% |
| Return on Invested Capital (ROIC) | -4.75% | -3.19% | -11.10% | 15.64% | 0.75% |
| Return on Tangible Assets | -10.17% | -10.39% | -10.10% | -10.05% | -1.68% |
| Earnings Yield | -64.99% | -46.13% | -23.77% | -40.20% | -2.51% |
| Efficiency Ratios | |||||
| Receivables Turnover | 9.54 | 11.23 | 6.08 | 13.21 | 15.14 |
| Payables Turnover | 16.97 | 3.09 | 2.82 | 3.71 | 3.00 |
| Inventory Turnover | 232.84 | 37.31 | 25.36 | 33.65 | 23.28 |
| Fixed Asset Turnover | 1.01 | 1.04 | 0.89 | 0.88 | 0.87 |
| Asset Turnover | 0.79 | 0.82 | 0.66 | 0.70 | 0.67 |
| Working Capital Turnover Ratio | -1.24 | -1.34 | -2.19 | -3.33 | -4.79 |
| Cash Conversion Cycle | 18.33 | -76.01 | -54.85 | -60.01 | -81.92 |
| Days of Sales Outstanding | 38.27 | 32.51 | 59.98 | 27.64 | 24.11 |
| Days of Inventory Outstanding | 1.57 | 9.78 | 14.39 | 10.85 | 15.68 |
| Days of Payables Outstanding | 21.51 | 118.31 | 129.22 | 98.50 | 121.71 |
| Operating Cycle | 39.83 | 42.30 | 74.38 | 38.48 | 39.79 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.67 | 0.72 | 0.12 | 0.21 | 0.82 |
| Free Cash Flow Per Share | 0.53 | 0.66 | -0.07 | 0.11 | 0.73 |
| Dividend Paid and CapEx Coverage Ratio | 4.89 | 12.39 | 0.64 | 2.16 | 8.96 |
| Capital Expenditure Coverage Ratio | 4.89 | 12.39 | 0.64 | 2.16 | 8.96 |
| Operating Cash Flow Coverage Ratio | 0.08 | 0.09 | 0.02 | 0.04 | 0.14 |
| Operating Cash Flow to Sales Ratio | 0.12 | 0.13 | 0.02 | 0.04 | 0.15 |
| Free Cash Flow Yield | 52.19% | 48.59% | -2.40% | 6.64% | 15.03% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.55 | -2.16 | -4.21 | -2.49 | -39.79 |
| Price-to-Sales (P/S) Ratio | 0.18 | 0.25 | 0.59 | 0.33 | 0.91 |
| Price-to-Book (P/B) Ratio | -0.27 | -0.43 | -1.12 | -0.89 | -4.02 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 1.92 | 2.06 | -41.65 | 15.06 | 6.65 |
| Price-to-Operating Cash Flow Ratio | 1.52 | 1.89 | 23.76 | 8.09 | 5.91 |
| Price-to-Earnings Growth (PEG) Ratio | -0.32 | 0.29 | -2.82 | -0.01 | 0.54 |
| Enterprise Value Multiple | 49.27 | 17.84 | 36.43 | 88.06 | 14.24 |
| Enterprise Value | 200.71M | 191.06M | 171.77M | 150.77M | 213.07M |
| EV to EBITDA | 49.27 | 17.84 | 36.43 | 88.06 | 14.24 |
| EV to Sales | 1.70 | 1.68 | 1.68 | 1.41 | 1.91 |
| EV to Free Cash Flow | 17.98 | 13.79 | -119.29 | 64.82 | 13.91 |
| EV to Operating Cash Flow | 14.31 | 12.67 | 68.06 | 34.83 | 12.36 |
| Tangible Book Value Per Share | -4.47 | -3.82 | -3.12 | -2.43 | -1.66 |
| Shareholders’ Equity Per Share | -3.84 | -3.19 | -2.56 | -1.87 | -1.21 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.09 | -0.28 | -0.13 | -0.08 | -0.24 |
| Revenue Per Share | 5.63 | 5.44 | 4.88 | 5.09 | 5.31 |
| Net Income Per Share | -0.66 | -0.63 | -0.68 | -0.67 | -0.12 |
| Tax Burden | 1.09 | 1.28 | 1.13 | 0.93 | 1.18 |
| Interest Burden | 2.69 | 5.56 | 2.50 | 1.62 | -0.56 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.03 | 0.04 | 0.04 | 0.03 | 0.03 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -1.10 | -1.47 | -0.18 | -0.34 | -8.78 |
Currency in EUR
